US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 19.7100
  • +0.7100+3.74%
Close Nov 21 16:00 ET
  • 19.5100
  • -0.2000-1.01%
Post 20:01 ET
104.03MMarket Cap-9954P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-23.77%1.57M
-23.17%1.79M
-31.75%1.72M
-16.19%8.83M
-34.27%1.91M
-14.18%2.07M
-15.75%2.33M
2.76%2.53M
15.44%10.54M
8.50%2.91M
Selling and administrative expenses
-21.19%590.62K
-10.32%657.81K
-13.12%757.28K
9.70%3.23M
8.73%876.4K
11.01%749.47K
7.10%733.5K
11.86%871.68K
11.82%2.95M
15.40%806.03K
-General and administrative expense
-21.19%590.62K
-10.32%657.81K
-13.12%757.28K
9.70%3.23M
8.73%876.4K
11.01%749.47K
7.10%733.5K
11.86%871.68K
11.82%2.95M
15.40%806.03K
Research and development costs
-25.24%984.28K
-29.08%1.13M
-41.57%966.11K
-26.23%5.6M
-50.76%1.04M
-24.00%1.32M
-23.27%1.59M
-1.46%1.65M
16.92%7.59M
6.07%2.1M
Operating profit
23.77%-1.57M
23.17%-1.79M
31.75%-1.72M
16.19%-8.83M
34.27%-1.91M
14.18%-2.07M
15.75%-2.33M
-2.76%-2.53M
-15.44%-10.54M
-8.50%-2.91M
Net non-operating interest income expense
-11.51%99.34K
-42.70%73.48K
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
1,358.30%112.26K
30,647.72%128.22K
19,401.72%90.49K
-11.59%21.24K
2,311.43%12.66K
Non-operating interest income
-11.51%99.34K
-42.70%73.48K
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
1,358.30%112.26K
30,647.72%128.22K
19,401.72%90.49K
-11.59%21.24K
2,311.43%12.66K
Other net income (expense)
171.28K
Other non- operating income (expenses)
--171.28K
----
----
----
----
----
----
----
----
----
Income before tax
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Income tax
Net income
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Net income continuous Operations
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Minority interest income
Net income attributable to the parent company
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
Basic earnings per share
46.38%-0.37
37.50%-0.5
47.37%-0.5
26.51%-3.05
46.09%-0.62
27.37%-0.69
27.27%-0.8
0.00%-0.95
-13.70%-4.15
-9.52%-1.15
Diluted earnings per share
46.38%-0.37
37.50%-0.5
47.37%-0.5
26.51%-3.05
46.09%-0.62
27.37%-0.69
27.27%-0.8
0.00%-0.95
-13.70%-4.15
-9.52%-1.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -23.77%1.57M-23.17%1.79M-31.75%1.72M-16.19%8.83M-34.27%1.91M-14.18%2.07M-15.75%2.33M2.76%2.53M15.44%10.54M8.50%2.91M
Selling and administrative expenses -21.19%590.62K-10.32%657.81K-13.12%757.28K9.70%3.23M8.73%876.4K11.01%749.47K7.10%733.5K11.86%871.68K11.82%2.95M15.40%806.03K
-General and administrative expense -21.19%590.62K-10.32%657.81K-13.12%757.28K9.70%3.23M8.73%876.4K11.01%749.47K7.10%733.5K11.86%871.68K11.82%2.95M15.40%806.03K
Research and development costs -25.24%984.28K-29.08%1.13M-41.57%966.11K-26.23%5.6M-50.76%1.04M-24.00%1.32M-23.27%1.59M-1.46%1.65M16.92%7.59M6.07%2.1M
Operating profit 23.77%-1.57M23.17%-1.79M31.75%-1.72M16.19%-8.83M34.27%-1.91M14.18%-2.07M15.75%-2.33M-2.76%-2.53M-15.44%-10.54M-8.50%-2.91M
Net non-operating interest income expense -11.51%99.34K-42.70%73.48K-9.20%82.17K1,920.05%429.04K674.67%98.07K1,358.30%112.26K30,647.72%128.22K19,401.72%90.49K-11.59%21.24K2,311.43%12.66K
Non-operating interest income -11.51%99.34K-42.70%73.48K-9.20%82.17K1,920.05%429.04K674.67%98.07K1,358.30%112.26K30,647.72%128.22K19,401.72%90.49K-11.59%21.24K2,311.43%12.66K
Other net income (expense) 171.28K
Other non- operating income (expenses) --171.28K------------------------------------
Income before tax 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Income tax
Net income 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Net income continuous Operations 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Minority interest income
Net income attributable to the parent company 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M
Basic earnings per share 46.38%-0.3737.50%-0.547.37%-0.526.51%-3.0546.09%-0.6227.37%-0.6927.27%-0.80.00%-0.95-13.70%-4.15-9.52%-1.15
Diluted earnings per share 46.38%-0.3737.50%-0.547.37%-0.526.51%-3.0546.09%-0.6227.37%-0.6927.27%-0.80.00%-0.95-13.70%-4.15-9.52%-1.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data